Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation.
about
Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafAFishing for Nature's Hits: Establishment of the Zebrafish as a Model for Screening Antidiabetic Natural ProductsThe emerging use of zebrafish to model metabolic diseaseWhole organism high content screening identifies stimulators of pancreatic beta-cell proliferationMetabolic insights from zebrafish genetics, physiology, and chemical biologyLarval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatmentSemi-automated imaging of tissue-specific fluorescence in zebrafish embryos.Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer.15 years of zebrafish chemical screeningNeurogenin 3 Expressing Cells in the Human Exocrine Pancreas Have the Capacity for Endocrine Cell Fate.Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells.Evaluating human cancer cell metastasis in zebrafish.Aldh1-expressing endocrine progenitor cells regulate secondary islet formation in larval zebrafish pancreas.In vitro screening for drug repositioning.Differential levels of Neurod establish zebrafish endocrine pancreas cell fates.Chemical genetics and regeneration.First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass.Small zebrafish in a big chemical pond.Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway.Chemical screening in zebrafish for novel biological and therapeutic discovery.Neural cells play an inhibitory role in pancreatic differentiation of pluripotent stem cells.Zebrafish models of human liver development and diseaseImaging beta cell regeneration and interactions with islet vasculature in transparent adult zebrafish.Learning to Fish with Genetics: A Primer on the Vertebrate Model Danio rerio.Modeling Pancreatic Endocrine Cell Adaptation and Diabetes in the Zebrafish.Advances in zebrafish chemical screening technologies.Use of zebrafish embryos for small molecule screening related to cancer.Targeting the pancreatic β-cell to treat diabetes.Zebrafish as tools for drug discovery.Centroacinar cells: At the center of pancreas regeneration.LITTLE FISH, BIG DATA: ZEBRAFISH AS A MODEL FOR CARDIOVASCULAR AND METABOLIC DISEASE.Identifying Novel Cancer Therapies Using Chemical Genetics and Zebrafish.Retinoic acid plays an evolutionarily conserved and biphasic role in pancreas development.ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates.Sox9b is a mediator of retinoic acid signaling restricting endocrine progenitor differentiation.An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infectionAssessment of Toxicological Perturbations and Variants of Pancreatic Islet Development in the Zebrafish Model.Redox stress and signaling during vertebrate embryonic development: Regulation and responses.Embryonic exposure to Mono(2-ethylhexyl) phthalate (MEHP) disrupts pancreatic organogenesis in zebrafish (Danio rerio).In vivo imaging of emerging endocrine cells reveals a requirement for PI3K-regulated motility in pancreatic islet morphogenesis.
P2860
Q21559495-A457F00E-D71F-4623-917B-E798D9FC05B0Q26774936-713AA3CF-74DA-46BD-8314-B688D85481D4Q26996802-C230512C-942A-412C-A0BA-0A2189FACA12Q27316605-9A3FCAE2-A4F6-497A-84A5-DE389751E89BQ28084257-9D414D2F-DF67-40A1-B2FC-E12DC3A75B2FQ28541293-743207F8-5060-4C71-BCFD-D4EADAE30281Q34312739-43D2D4F1-F54E-477E-A8F3-C60F24957DDEQ34402836-466FBA14-CCF3-4B8C-B919-12F01FA81D7EQ34451386-A760D417-6560-4927-958C-07A386257D4EQ34490166-A02E2A65-1DC4-4C90-8D8D-848C2D85A053Q34550486-7F34D8DE-A7BB-4304-8280-3591B40C9148Q35007082-7729D96D-2799-43F4-88AA-46E2D8F1FB52Q35023646-6A063C62-6537-442E-8774-D793F6C80DFEQ35531225-A2862941-9511-4D09-8338-8565400F4D66Q35612318-1060CEB6-4598-4BFA-B069-4818D8362011Q35825358-0D084224-7476-4B74-9F4A-FCDCEFA6BAFEQ35947964-CB4E364D-F0BF-4D71-BD78-8B0CB9E49C8DQ35951647-090E52A7-7261-47D6-AC1E-B17BA5C674E4Q36150902-C666944A-C4D8-4CCA-AE22-5B1BACD3B3F4Q36262938-80F0A2F9-D451-453F-89FC-0CC513895ACEQ36536555-63815925-C308-42C4-B4DA-076AD3CC0048Q36669372-4347DCA5-632A-4657-A931-E9435146FA5EQ36905302-53B4929A-592A-47F4-8CA7-8A7C66DFA211Q37076779-6FD98C8A-08AF-4E39-8EE1-2C96FA6BF43CQ37607133-869C335E-D155-4F1A-8E1F-1BA6DE1C31C8Q38050177-ECB55F09-B83C-4233-B501-2B7E65C13B67Q38064359-181149C2-B951-4DB8-B032-F4AFABA00D73Q38187862-86F589C2-395B-4E44-A33E-978321A743DEQ38585048-01785EB0-CAF5-4582-B156-D14CEF9D9B00Q38768585-BF75A315-3019-46DC-B956-29BD4D0AF71BQ38806486-20324EBD-5D09-40A8-A8BB-0F30D0B6A6AEQ38831323-0BBE4E85-AC24-458A-B355-CE26174C2CFCQ38965604-D3275CC8-2EED-483C-A0E9-7FB269CEE44AQ41496032-6A7A63BF-739A-4F04-8C5E-81A56A650713Q41639895-F0499B68-B99C-414E-9F21-6AD13387C1D3Q41961224-B82EC981-8667-43A7-8BB6-B0671AAEAB07Q42292845-3CC59A3B-FECA-4D13-ACFC-72F120A1B314Q46304317-7680D234-4B02-4468-8190-371CFF0A56B4Q47250609-B3EECBE6-2C46-4BD8-9138-3BF49331F1ACQ47554062-AA8D93FF-78A8-4582-B22A-D8E0C465B572
P2860
Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chemical screen identifies FDA ...... tic endocrine differentiation.
@ast
Chemical screen identifies FDA ...... tic endocrine differentiation.
@en
Chemical screen identifies FDA ...... tic endocrine differentiation.
@nl
type
label
Chemical screen identifies FDA ...... tic endocrine differentiation.
@ast
Chemical screen identifies FDA ...... tic endocrine differentiation.
@en
Chemical screen identifies FDA ...... tic endocrine differentiation.
@nl
prefLabel
Chemical screen identifies FDA ...... tic endocrine differentiation.
@ast
Chemical screen identifies FDA ...... tic endocrine differentiation.
@en
Chemical screen identifies FDA ...... tic endocrine differentiation.
@nl
P2093
P2860
P356
P1476
Chemical screen identifies FDA ...... tic endocrine differentiation.
@en
P2093
Anthony A Ferrante
Joong Sup Shim
Meritxell Rovira
Michael J Parsons
Shamila Yusuff
P2860
P304
19264-19269
P356
10.1073/PNAS.1113081108
P407
P577
2011-11-14T00:00:00Z